Position in NVAX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$151,614
+$18,681 QoQ
Shares Held
16,095
-1.4% QoQ
Ownership
0.010%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#147
of 263 holders
Holding Since
Mar 2020
23 quarters on record
Voting authority
Sole 0%
Shared 89%
None 11%
Common Shares in NVAX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026AMERIPRISE FINANCIAL INC holds $5,025,615,702 across 202 Biotechnology names. NVAX ranks #193 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,604,822 | $1,293,893,227 | |
| 2 | INSM |
INSMED Inc
|
6,179,571 | $658,865,856 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
1,215,523 | $292,904,576 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
1,039,702 | $194,715,388 | |
| 5 | ARGX |
Argenx SE
|
181,464 | $168,356,853 | |
| 6 | REGN |
Regeneron Pharmaceuticals, Inc.
|
227,457 | $141,828,535 | |
| 7 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
231,205 | $124,145,521 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
1,551,663 | $115,567,858 |
All Filings in NVAX
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $151,614 | 16,095 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $132,933 | 16,331 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $109,307 | 16,266 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $165,466 | 19,085 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $120,267 | 19,090 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $203,491 | 31,746 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $265,770 | 33,056 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $211,640 | 16,757 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $364,278 | 28,774 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $153,624 | 32,139 | Shares | Defined | 2024-05-15 | |
| 2023-09-30 | $227,233 | 31,386 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $608,189 | 81,856 | Shares | Defined | 2023-08-14 | |
| 2022-12-31 | $297,338 | 28,924 | Shares | Defined | 2023-02-14 | |
| 2022-06-30 | $12,304,678 | 239,251 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $2,946,513 | 40,007 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $42,680,068 | 298,316 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $21,547,800 | 103,940 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $135,472,461 | 638,088 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $108,679,026 | 599,410 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $96,741,613 | 867,560 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $66,566,663 | 614,367 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $4,064,728 | 48,767 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $178,209 | 13,123 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||